New type of painkiller approved in US

Vertex

Source: © Business Wire

Sodium channel blocker prevents nerves transmitting pain signals

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA). Vertex’s Journavx (suzetrigine), can be used to treat moderate to severe acute pain in adults.